Concentrix (NASDAQ:CNXC) Stock Keeps Buy Rating at Canaccord Genuity Group

Concentrix (NASDAQ:CNXC - Get Free Report)'s stock had its "buy" rating restated by analysts at Canaccord Genuity Group in a research report issued to clients and investors on Wednesday, Benzinga reports. They currently have a $45.00 target price on the stock. Canaccord Genuity Group's target price points to a potential upside of 71.19% from the company's current price.

Several other analysts have also commented on CNXC. Zacks Research raised Concentrix from a "strong sell" rating to a "hold" rating in a report on Monday, August 31st. Bank of America dropped their price objective on Concentrix from $32.00 to $26.00 and set a "neutral" rating on the stock in a report on Tuesday, June 30th. Weiss Ratings reissued a "sell (d)" rating on shares of Concentrix in a report on Friday, July 24th. Robert W. Baird dropped their price objective on Concentrix from $40.00 to $30.00 and set an "outperform" rating on the stock in a report on Tuesday, June 30th. Finally, Barrington Research dropped their price objective on Concentrix from $38.00 to $30.00 and set an "outperform" rating on the stock in a report on Tuesday, June 30th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $32.75.

Concentrix Stock Performance

Concentrix stock traded up $1.41 during midday trading on Wednesday, hitting $26.29. 2,491,824 shares of the company were exchanged, compared to its average volume of 1,639,798. The firm has a market capitalization of $1.60 billion, a PE ratio of -1.23, a price-to-earnings-growth ratio of 0.47 and a beta of 0.47. Concentrix has a fifty-two week low of $19.12 and a fifty-two week high of $49.37. The business has a fifty day simple moving average of $27.01 and a two-hundred day simple moving average of $26.53. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.18 and a current ratio of 1.18.

Concentrix (NASDAQ:CNXC - Get Free Report) last posted its earnings results on Tuesday, September 29th. The company reported $2.92 EPS for the quarter, topping the consensus estimate of $2.71 by $0.21. The firm had revenue of $2.45 billion for the quarter, compared to analyst estimates of $2.48 billion. Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.Concentrix's revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period last year, the company earned $2.78 earnings per share. Concentrix has set its FY 2026 guidance at 10.970-11.090 EPS and its Q4 2026 guidance at 2.860-2.980 EPS. On average, sell-side analysts forecast that Concentrix will post 9.67 earnings per share for the current year.

Institutional Trading of Concentrix

Institutional investors have recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in shares of Concentrix in the second quarter worth approximately $149,639,000. Dimensional Fund Advisors LP boosted its stake in shares of Concentrix by 18.5% in the first quarter. Dimensional Fund Advisors LP now owns 2,951,378 shares of the company's stock worth $80,746,000 after acquiring an additional 460,108 shares during the last quarter. Pzena Investment Management LLC boosted its stake in shares of Concentrix by 0.5% in the first quarter. Pzena Investment Management LLC now owns 2,943,212 shares of the company's stock worth $80,526,000 after acquiring an additional 16,016 shares during the last quarter. Groupe Bruxelles Lambert acquired a new stake in shares of Concentrix in the second quarter worth approximately $68,000,000. Finally, Kopernik Global Investors LLC acquired a new stake in shares of Concentrix in the first quarter worth approximately $44,523,000. 90.34% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Concentrix reported third-quarter adjusted earnings of $2.92 per share, exceeding the $2.71 analyst consensus and rising from $2.78 a year earlier. The company also exceeded its profitability guidance. Concentrix Corporation Q3 Earnings Beat Estimates
• Positive Sentiment: Operating cash flow reached a quarterly record of $268 million, while adjusted free cash flow was $218 million, supporting capital returns and balance-sheet management. Concentrix Reports Third Quarter 2026 Results
• Positive Sentiment: The quarterly dividend was raised 2.8% to $0.37 per share, or $1.48 annualized, providing an indicated yield of approximately 5.6%. Concentrix Reports Third Quarter 2026 Results
• Neutral Sentiment: Full-year EPS guidance of $10.97-$11.09 is above the $10.89 consensus, but fiscal-year revenue guidance of $9.8-$9.9 billion trails the $10.0 billion estimate.
• Negative Sentiment: Third-quarter revenue of $2.45 billion missed the $2.48 billion consensus and declined 1.2% year over year. Investors are concerned that the transition toward AI-related services is weighing on current revenue. Concentrix Stock Falls After Earnings as AI Transition Weighs on Revenue
• Negative Sentiment: Fourth-quarter EPS guidance of $2.86-$2.98 and revenue guidance of $2.4-$2.5 billion both came in below analyst expectations of $3.08 and $2.5 billion, respectively.

About Concentrix

Concentrix Corporation is a global technology and services company that helps organizations manage customer experience, business operations and digital transformation. Its offerings include customer care, technical support, sales and marketing services, back-office support, analytics, artificial intelligence and automation solutions.

The company serves clients across industries such as technology and consumer electronics, retail, banking and financial services, healthcare, communications and media, travel, and automotive.